184 related articles for article (PubMed ID: 37737566)
21. An alternative splice product of IkappaB kinase (IKKgamma), IKKgamma-delta, differentially mediates cytokine and human T-cell leukemia virus type 1 tax-induced NF-kappaB activation.
Hai T; Yeung ML; Wood TG; Wei Y; Yamaoka S; Gatalica Z; Jeang KT; Brasier AR
J Virol; 2006 May; 80(9):4227-41. PubMed ID: 16611882
[TBL] [Abstract][Full Text] [Related]
22. Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells.
Tamatani T; Azuma M; Aota K; Yamashita T; Bando T; Sato M
Cancer Lett; 2001 Oct; 171(2):165-72. PubMed ID: 11520600
[TBL] [Abstract][Full Text] [Related]
23. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
[TBL] [Abstract][Full Text] [Related]
24. All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex.
Heilker R; Freuler F; Pulfer R; Di Padova F; Eder J
Eur J Biochem; 1999 Jan; 259(1-2):253-61. PubMed ID: 9914500
[TBL] [Abstract][Full Text] [Related]
25. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IKK-IkappaB-NF-kappaB pathway in IgE-dependent mast cell activation.
Peng Y; Power MR; Li B; Lin TJ
J Leukoc Biol; 2005 Jun; 77(6):975-83. PubMed ID: 15784689
[TBL] [Abstract][Full Text] [Related]
27. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
[TBL] [Abstract][Full Text] [Related]
29. 17-Acetoxyjolkinolide B irreversibly inhibits IkappaB kinase and induces apoptosis of tumor cells.
Yan SS; Li Y; Wang Y; Shen SS; Gu Y; Wang HB; Qin GW; Yu Q
Mol Cancer Ther; 2008 Jun; 7(6):1523-32. PubMed ID: 18566223
[TBL] [Abstract][Full Text] [Related]
30. 2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase.
Kuang S; Qi C; Liu J; Sun X; Zhang Q; Sima Z; Liu J; Li W; Yu Q
Cancer Sci; 2014 Apr; 105(4):473-80. PubMed ID: 24450414
[TBL] [Abstract][Full Text] [Related]
31. The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice.
Huber MA; Denk A; Peter RU; Weber L; Kraut N; Wirth T
J Biol Chem; 2002 Jan; 277(2):1268-75. PubMed ID: 11694538
[TBL] [Abstract][Full Text] [Related]
32. NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation.
Hu WH; Pendergast JS; Mo XM; Brambilla R; Bracchi-Ricard V; Li F; Walters WM; Blits B; He L; Schaal SM; Bethea JR
J Biol Chem; 2005 Aug; 280(32):29233-41. PubMed ID: 15951441
[TBL] [Abstract][Full Text] [Related]
33. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation.
Nomura F; Kawai T; Nakanishi K; Akira S
Genes Cells; 2000 Mar; 5(3):191-202. PubMed ID: 10759890
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells.
Vertegaal AC; Kuiperij HB; Yamaoka S; Courtois G; van der Eb AJ; Zantema A
Cell Signal; 2000 Dec; 12(11-12):759-68. PubMed ID: 11152962
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of JNK activation through NF-kappaB target genes.
Tang G; Minemoto Y; Dibling B; Purcell NH; Li Z; Karin M; Lin A
Nature; 2001 Nov; 414(6861):313-7. PubMed ID: 11713531
[TBL] [Abstract][Full Text] [Related]
37. IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.
Li X; Massa PE; Hanidu A; Peet GW; Aro P; Savitt A; Mische S; Li J; Marcu KB
J Biol Chem; 2002 Nov; 277(47):45129-40. PubMed ID: 12221085
[TBL] [Abstract][Full Text] [Related]
38. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.
Wu ZH; Shi Y; Tibbetts RS; Miyamoto S
Science; 2006 Feb; 311(5764):1141-6. PubMed ID: 16497931
[TBL] [Abstract][Full Text] [Related]
39. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
40. Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta.
Weber CK; Liptay S; Wirth T; Adler G; Schmid RM
Gastroenterology; 2000 Nov; 119(5):1209-18. PubMed ID: 11054378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
